Russell Investments Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-57,126
Closed -$7.78M – 3290
2020
Q3
$7.78M Buy
57,126
+10,511
+23% +$1.12M 0.02% 902
2020
Q2
$4.5M Buy
46,615
+15,297
+49% +$1.28M 0.01% 1154
2020
Q1
$1.47M Buy
+31,318
New +$2.01M ﹤0.01% 1636
2017
Q4
– Sell
-822
Closed -$35K – 3038
2017
Q3
$35K Buy
+822
New +$26.2K ﹤0.01% 2888

Russell Investments Group's MYOK Position: Q4 2020 in Review

Russell Investments Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 57,126 shares — an estimated $7.78M sold.

Russell Investments Group first reported a position in MYOK in Q3 2017 and held it in 4 quarters. The position peaked at $7.78M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Russell Investments Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Russell Investments Group sold 57,126 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $7.78M.
  • Russell Investments Group first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 4 quarters.
  • Russell Investments Group's MyoKardia, Inc. Common Stock position peaked at $7.78M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Russell Investments Group's 13F filing for Q4 2020, filed 8 Feb 2021.